Judge allows class-action lawsuit against Walgreen over generic drug prices to go forward; the United States may implement medical deliveries by drone; House introduces its right-to-try legislation.
Walgreen has been accused of overcharging customers for generic drugs purchased using private insurance, Medicare, and Medicaid. According to Reuters, the company is being accused of charging insured customers more for generic drugs than it charged members of Walgreen’s Prescription Savings Club. Plaintiffs claimed that the company misled their insurers by reporting higher prices, and that they had believed that by having insurance they would pay at least the same amount as direct-pay customers. The federal judge did dismiss 2 of the 29 claims.
The Federal Aviation Administration (FAA) is currently reviewing 149 proposals, many of which are health-related, on how to integrate drones into the national airspace. In the United States, it has to be determined that the drones can fly safely alongside commercial jets and anything else that is already in the sky, NPR reported. Among the proposals submitted to the FAA is one from the University of Washington in Seattle to test carrying blood samples over the Puget Sound.
In August 2017, the Senate passed right-to-try legislation, and the House is now moving to pass its own version. The House Energy and Commerce Committee released a new version of the bill, which requires patients to have exhausted all approved treatment options and use a drug that has passed a stage 1 clinical trial, according to The Wall Street Journal. Although Congress is interested in passing a right-to-try bill, and the White House has been a proponent, FDA Commissioner Scott Gottlieb, MD, has been skeptical of the benefits of right-to-try legislation.
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been falling. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Males With Hemophilia A Report Physical, Mental Burdens of Disease Regardless of Severity
April 25th 2024Self-reported data from adult and pediatric males with hemophilia A show that burden of the disease persists regardless of severity, highlighting a need for improved prophylactic treatment.
Read More
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More